Nov 11, 2010 12:00pm EST SCYNEXIS Receives Four Grants Under Federal Therapeutic Discovery Project Program
Sep 14, 2010 8:52am EDT SCYNEXIS Announces Presentations of Data From Anti-Fungal Drug Candidate at the 50th ICAAC Meeting
May 19, 2010 8:08am EDT SCYNEXIS and Trevena Announce Strategic Collaboration to Enhance Discovery of Biased GPCR Ligands
Apr 16, 2010 9:35am EDT SCYNEXIS Presents In Vitro Toxicity Study Suggesting that SCY-635 is Unique in the Cyclophilin Inhibitor Class
Apr 15, 2010 12:01pm EDT SCYNEXIS' SCY-635 Demonstrates Impressive Barrier to Resistance in HCV Treatment
Apr 05, 2010 9:35am EDT SCYNEXIS Announces Acceptance of Abstracts Related to its Hepatitis C Clinical Candidate, SCY-635, for Presentation at 45th Annual Meeting of the European Association for the Study of the Liver
